Wolverine Trading, LLC Alkermes Plc. Transaction History
Wolverine Trading, LLC
- $83.2 Billion
- Q1 2025
A detailed history of Wolverine Trading, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 11,256 shares of ALKS stock, worth $352,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,256
Previous 8,607
30.78%
Holding current value
$352,200
Previous $247,000
50.2%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$911 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$570 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$369 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$251 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$215 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.14B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...